Search all trials

Find therapies in clinical trials near you – page 27

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced or Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Metastatic malignant melanoma

Not recruiting

Registered drugNo placebo

Study of IO102-IO103 and Pembrolizumab for Patients with Advanced Melanoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Io102 Hydrochloride

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study of Osimertinib and Chemotherapy for Patients with EGFR Mutation Positive Resectable Non-Small Cell Lung Cancer

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Lupus nephritis+1

Not recruiting

Investigational

Study on Vemircopan for Adults with Lupus Nephritis or IgA Nephropathy

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Vemircopan

Contact Research Centre

Adult T-cell lymphoma/leukaemia+2

Not recruiting

Registered drugNo placebo

Study of Selinexor, Ifosfamide, Etoposide, and Dexamethasone for Patients with Relapsed or Refractory Peripheral T-cell Lymphomas

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Etoposide

Contact Research Centre

Diffuse large B-cell lymphoma

Not recruiting

Registered drug

Study on Acalabrutinib with Drug Combination for Patients 75 and Older with Untreated Diffuse Large B-Cell Lymphoma

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Acalabrutinib

Contact Research Centre

Non-small cell lung cancer+2

Not recruiting

Registered drug

Study on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy

Registered drug

Italy

Participants:18–64 years · 65+ years

Contact Research Centre

Focal segmental glomerulosclerosis

Not recruiting

Investigational

Study of BI 764198 for Patients with Focal Segmental Glomerulosclerosis

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study of Selpercatinib for Patients with Early-Stage RET Fusion-Positive Non-Small Cell Lung Cancer After Local Treatment

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Selpercatinib

Contact Research Centre

Bladder transitional cell carcinoma

Not recruiting

Registered drugNo placebo

Study of RO7247669, Tiragolumab, and Atezolizumab for Patients with Untreated Advanced Urothelial Cancer Ineligible for Platinum Chemotherapy

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Marginal zone lymphoma

Not recruiting

Registered drugNo placebo

Study of Ibrutinib and Rituximab for Patients with Untreated Marginal Zone Lymphoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Ibrutinib

Contact Research Centre

Bladder cancer

Not recruiting

Registered drugNo placebo

Study Comparing Chemotherapy Alone to Chemotherapy with Nivolumab or Nivolumab and BMS-986205 for Patients with Muscle-Invasive Bladder Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Find therapies in clinical trials near you – page 27

392 trials match your criteria

Non-small cell lung cancer

Study of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced or Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations

Metastatic malignant melanoma

Study of IO102-IO103 and Pembrolizumab for Patients with Advanced Melanoma

Non-small cell lung cancer

Study of Osimertinib and Chemotherapy for Patients with EGFR Mutation Positive Resectable Non-Small Cell Lung Cancer

Lupus nephritis+1

Study on Vemircopan for Adults with Lupus Nephritis or IgA Nephropathy

Adult T-cell lymphoma/leukaemia+2

Study of Selinexor, Ifosfamide, Etoposide, and Dexamethasone for Patients with Relapsed or Refractory Peripheral T-cell Lymphomas

Diffuse large B-cell lymphoma

Study on Acalabrutinib with Drug Combination for Patients 75 and Older with Untreated Diffuse Large B-Cell Lymphoma

Non-small cell lung cancer+2

Study on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy

Focal segmental glomerulosclerosis

Study of BI 764198 for Patients with Focal Segmental Glomerulosclerosis

Non-small cell lung cancer

Study of Selpercatinib for Patients with Early-Stage RET Fusion-Positive Non-Small Cell Lung Cancer After Local Treatment

Bladder transitional cell carcinoma

Study of RO7247669, Tiragolumab, and Atezolizumab for Patients with Untreated Advanced Urothelial Cancer Ineligible for Platinum Chemotherapy

Marginal zone lymphoma

Study of Ibrutinib and Rituximab for Patients with Untreated Marginal Zone Lymphoma

Bladder cancer

Study Comparing Chemotherapy Alone to Chemotherapy with Nivolumab or Nivolumab and BMS-986205 for Patients with Muscle-Invasive Bladder Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.